TRMB:NASDAQTrimble Inc. Analysis
Data as of 2026-03-11 - not real-time
$68.99
Latest Price
7/10Risk
Risk Level: Medium
Executive Summary
Trimble Inc. (TRMB) is trading at $68.99, just above its 20‑day SMA of $67.79 but well below the 50‑day SMA of $71.42 and the 200‑day SMA of $77.28, indicating a bearish medium‑term trend. The RSI sits near 50 (49.68), suggesting neutral momentum, while the MACD histogram is positive (0.64) despite the MACD line being above the signal line, giving a mixed short‑term signal. Volatility is elevated at 34% over the past 30 days and beta exceeds 1.3, pointing to higher price swings than the market. The current price is far above the DCF‑derived fair value of $25.02, implying the stock is significantly overvalued with an upside/downside metric of –31.9% relative to intrinsic value. Nevertheless, the company posted a Q4 EPS of $1.00 beating estimates, reported 14% ARR growth to $2.39 bn, and raised FY 2025 guidance, underscoring strong earnings momentum. The forward PE of 17 is dramatically lower than the trailing PE of 39, hinting potential valuation compression if earnings sustain. With a debt‑to‑equity of 26.7 and no dividend, cash flow remains solid but leverage is notable.
Strategically, Trimble is emphasizing AI‑enabled productivity, tuck‑in acquisitions in construction software, and expanding recurring revenue through its Connect & Scale platform, positioning it for long‑term growth in the AECO and field systems markets. However, the bearish technical backdrop, high volatility, and current overvaluation suggest caution in the near term while the fundamentals and strategic initiatives support a more optimistic medium‑ to long‑term outlook.
Strategically, Trimble is emphasizing AI‑enabled productivity, tuck‑in acquisitions in construction software, and expanding recurring revenue through its Connect & Scale platform, positioning it for long‑term growth in the AECO and field systems markets. However, the bearish technical backdrop, high volatility, and current overvaluation suggest caution in the near term while the fundamentals and strategic initiatives support a more optimistic medium‑ to long‑term outlook.
Market Outlook
Short Term
< 1 yearNeutral
Model confidence: 6/10
Key Factors
- Bearish medium‑term SMA alignment
- High 30‑day volatility and beta
- Recent earnings beat but price overvaluation
Medium Term
1–3 yearsPositive
Model confidence: 7/10
Key Factors
- Strong ARR growth and AI‑driven product roadmap
- Forward PE compression to 17x
- Strategic acquisitions expanding recurring revenue
Long Term
> 3 yearsNeutral
Model confidence: 6/10
Key Factors
- Sustained recurring‑revenue model in construction and logistics
- Elevated leverage but solid operating cash flow
- Valuation gap versus DCF fair value requiring price correction
Key Metrics & Analysis
Financial Health
Revenue Growth-1.40%
Profit Margin11.82%
P/E Ratio39.2
ROE7.32%
ROA4.11%
Debt/Equity26.75
P/B Ratio2.8
Op. Cash Flow$386.2M
Free Cash Flow$522.8M
Industry P/E36.8
Technical Analysis
TrendBearish
RSI49.7
Support$64.50
Resistance$70.82
MA 20$67.79
MA 50$71.42
MA 200$77.28
MACDBullish
VolumeDecreasing
Fear & Greed Index76.91
Valuation
Fair Value$25.02
Target Price$91.00
Upside/Downside31.90%
GradeOvervalued
TypeGrowth
Risk Assessment
Beta1.34
Volatility34.02%
Sector RiskHigh
Reg. RiskMedium
Geo RiskMedium
Currency RiskMedium
Liquidity RiskLow
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.